Literature DB >> 8275705

Regional localization of loci on chromosome 14 using somatic cell hybrids.

G D Billingsley1, D W Cox, A M Duncan, P J Goodfellow, K H Grzeschik.   

Abstract

We have used a panel of human x rodent somatic cell hybrids containing translocations involving chromosome 14 to regionally localize 17 genes and 5 random segments previously mapped to chromosome 14. Each hybrid cell line contains a specific fragment of chromosome 14, with breakpoints at 14q11.2, 14q21, 14q22, 14q24.3 or in two different regions of 14q32.1. The enzyme deficient in glycogen storage disease type VI, liver glycogen phosphorylase (PYGL), has been localized by in situ hybridization to 14q21-->q22, near the q21-->q22 band interface. Four additional genes, chromogranin A (CHGA), myosin (MYH7), tRNA proline 2 (TRP2) and c-FOS (FOS) and four random segments, D14S26, D14S12, D14S14 and D14S13 have been more precisely localized. This study also defines a hybrid cell panel with seven mapping intervals, that will be useful for further physical mapping of new loci.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275705     DOI: 10.1159/000133659

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  4 in total

Review 1.  Genetic deficiencies of the glycogen phosphorylase system.

Authors:  J Hendrickx; P J Willems
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  The CG-1 gene, a member of the kinectin and ES/130 family, maps to human chromosome band 14q22.

Authors:  C G Print; C M Morris; N K Spurr; L Rooke; G W Krissansen
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 3.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

4.  Molecular analysis of three patients with interstitial deletions of chromosome band 14q31.

Authors:  B C Byth; M T Costa; I E Teshima; W G Wilson; N P Carter; D W Cox
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.